Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee

Osteoarthritis and Cartilage

Volumn 15, Issue 12, 2007, Pages 1424-1436

  Campbell, J ^a   Bellamy, N ^b   Gee, T ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Hyaluronan; Hyaluronic acid; Hylan; Knee; Meta analysis; Osteoarthritis; Systematic review

Indexed keywords

HYALURONIC ACID; HYLAN GF 20; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; UNCLASSIFIED DRUG;

ALGORITHM; ANALGESIA; ARTICLE; CLINICAL TRIAL; DATA COLLECTION METHOD; DECISION SUPPORT SYSTEM; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; META ANALYSIS; METHODOLOGY; OUTCOMES RESEARCH; PATIENT SELECTION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RISK BENEFIT ANALYSIS; RISK REDUCTION; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TIME;

ALGORITHMS; HUMANS; HYALURONIC ACID; META-ANALYSIS AS TOPIC; OSTEOARTHRITIS, KNEE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELECTION BIAS;

EID: 35748940269     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.01.022     Document Type: Article

References (101)

1. Egger M., Davey Smith G., and O'Rourke K. Rationale, potentials, and promise of systematic reviews. In: Egger M., Davey Smith G., and Altman D.G. (Eds). Systematic Reviews in Health Care. Meta-analysis in context (2001), BMJ Publishing Group, London 3-19
2. Cook D.J., Mulrow C.D., and Haynes R.B. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 126 (1997) 376-380
3. Jadad A.R., Cook D.J., and Browman G.P. A guide to interpreting discordant systematic reviews. Can Med Assoc J 156 (1997) 1411-1416
4. Moayyedi P., Deeks J., Talley N.J., Delaney B., and Forman D. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 98 (2003) 2621-2626
5. Linde K., and Willich S.N. How objective are systematic reviews? Differences between reviews on complementary medicine. J Royal Soc Med 96 (2003) 17-22
6. Arrich J., Piribauer F., Mad P., Schmid D., Klaushofer K., and Müllner M. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172 (2005) 1039-1043
7. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. The Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD005321.pub2. DOI: 10.1002/14651858.CD005321. pub2.
8. Lo G.H., La Valley M., McAlindon T., and Felson D. Intra-articular hyaluronic acid in treatment of knee osteoarthritis. A meta-analysis. JAMA 290 (2003) 3115-3121
9. Medina J.M., Thomas A., and Denegar C.R. Knee osteoarthritis: should your patient opt for hyaluronic acid injection? A meta-analysis of randomized controlled trials. J Fam Pract 55 8 (2006) 669-675
10. Modawal A., Ferrer M., Choi H.K., and Castle J.A. Hyaluronic acid injections relieve knee pain. J Fam Pract 54 (2005) 758-767
11. Wang C.-T., Lin J., Change C.-J., Lin Y.-T., and Hou S.-M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg 86-A (2004) 538-545
12. The GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 328 (2004) 1490-1494
13. Adams M.E., Atkinson M.H., Lussier A.J., Schulz J.I., Siminovitch K.A., Wade J.P., et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian mulicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 3 (1995) 213-226
14. Altman R., Moskowitz R., and the Hyalgan Study Group. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial. J Rheumatol 25 (1998) 2203-2212
15. Altman R.D., Akermark C., Beaulieu A.D., and Schnitzer T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage 12 (2004) 642-649
16. Bragantini A., Cassini M., and De Bastiani G. Controlled single-blind trial of intra-articularly injected hyaluronic acid (Hyalgan) in osteoarthritis of the knee. Clin Trials J 24 (1987) 333-340
17. Brandt K.D., Block J.A., Michalski J.P., Moreland L.W., Caldwell J.R., Lavin P.T., and the ORTHOVISC Study Group. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. Clin Orthop 385 (2001) 130-143
18. Bunyaratavej N., Chang K.M., and Subramanian N. Treatment of painful osteoarthritis of the knee with hyaluronic acid results of a multicenter Asian study. J Med Assoc Thai 84 Suppl 2 (2001) 576-581
19. Carrabba M., Paresce E., Angelini M., Re K.A., Torchiana E.E.M., and Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 15 (1995) 25-31
20. Cohen M.A., Shiroky J.B., Ballachey M.-L., Neville C., and Esdaile J.M. Double-blind randomized trial of intra-articular (I/A) hyaluronate in the treatment of osteoarthritis of the knee. (Abstract). Arthritis Rheum 37 Suppl 6 (1994) R31
21. Corrado E.M., Peluso G.F., Gigliotti S., de Durante C., Palmieri D., Savoia M., et al. The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm 15 (1995) 47-56
22. Creamer P., Sharif M., George E., Meadows K., Cushnaghan J., Shinmei M., et al. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage 2 (1994) 133-140
23. Cubukcu D., Ardic F., Karabulut N., and Topuz O. Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol 24 4 (2005) 336-341
24. Dahlberg L., Lohmander L.S., and Ryd L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and nee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum 37 (1994) 521-528
25. Day R., Brooks P., Conaghan P.G., Petersen M., and for the Multicenter Trial Group. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol 31 4 (2004) 775-782
26. Dickson D.J., and Hosie G. English JR and the Primary Care Rheumatology Society OA Knee Study Group. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 4 (2001) 41-52
27. Dougados M., Nguyen M., Listrat V., and Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1 (1993) 97-103
28. La Sala F., and de Miguel R.E. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a short term study. Eur J Rheumatol Inflamm 15 (1995) 33-38
29. Graf J., Neusel E., Schneider E., and Niethard F.U. Intra-articular treatment with hyaluronic acid in osteoarthritis of the knee joint: a controlled clinical trial versus mucopolysaccharide polysulfuric acid ester. Clin Exp Rheumatol 11 (1993) 367-372
30. Grecomoro G., Martorana U., and Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 5 (1987) 137-141
31. Grecomoro G., Piccione F., and Letizia G. Therapeutic synergism between hyaluronic acid and dexamethasone in the intra-articular treatment of osteoarthritis of the knee: a preliminary open study. Cur Med Res Opin 13 (1992) 49-55
32. Groppa L.G., and Moshneaga M. Studying of the efficiency of the Synvisk in osteoarthrosis. (Abstract). Ann Rheum Dis 60 Suppl 1 (2001) 230
33. Guler M, Kuran B, Parlar D, Guler M, Saglam H, Yapici S, et al., Clinical trial of intra-articular injection of hyaluronic acid in patients with osteoarthritis of the knee. (Abstract) Poster presented at the X National Rheumatology Congress, October 29-November 3, 1996, Pamukkale-Denizli, Turkey.
34. Henderson E.B., Smith E.C., Pegley F., and Blake D.R. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 53 (1994) 529-534
35. Hizmetli S, Kocagil S. The efficacy and safety of intra-articular hyaluroan acid in gonarthrosis (a prospective, double-blind trial). (Unpublished manuscript).
36. Huskisson E.C., and Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 38 (1999) 602-607
37. Isdale A.H., Hordon L.D., Bird H.A., and Wright V. A controlled comparison of intra-articular healon (hyaluronate), triamcinolone and saline in osteoarthritis of the knee. (Abstract). Br J Rheumatol 32 Suppl 1 (1993) 61
38. Jones A.C., Patrick M., Doherty S., and Doherty M. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage 3 (1995) 269-273
39. Jubb R.W., Piva S., Beinat L., Dacre J., and Gishen P. Structure modifying study of hyaluronan (500-730 KDa, Hyalgan) on osteoarthritis of the knee. (Abstract). Arthritis Rheum 44 Suppl 9 (2001) S155
40. Jubb R.W., Piva S., Beinat L., Dacre J., and Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract 57 (2003) 467-474
41. Karlsson J., and Selin-Sjogren L. A comparison of two hyaluronan drugs and placebo in patients with mild to moderate osteoarthritis of the knee - a controlled, randomised, parallel-design multicenter study. (Abstract). Acta Orthop Scand 70 Suppl 287 (1999) 62
42. Karlsson J., Sjögren L.S., and Lohmander L.S. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 41 (2002) 1240-1248
43. Kotevoglu N., Iybozkurt P.C., Hz O., Toktas H., and Kuran B. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int 26 (2006) 325-330
44. Leardini G., Mattara L., Franceschini M., and Perbellini A. Intra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clin Exp Rheumatol 9 (1991) 375-381
45. Lin C-C, Tsai C-L, Lee C-H, Chang C-C, Chen S-C, Lai C-H, et al. Efficacy and safety of intra-articular injections of sodium hyaluronate (Hyalgan) in the treatment of osteoarthritis of the knee. A randomized, controlled trial. (Unpublished manuscript).
46. Lohmander L.S., Dalen N., Englund G., Hamalainen M., Jensen E.M., Karlsson K., et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Ann Rheum Dis 55 (1996) 424-431
47. Moreland L.W., Arnold W.J., Saway A., Savory C., and Sikes D. Efficacy and safety of intra-articular hylan G-F 20 (Synvisc), a viscoelastic derivative of hyaluronan, in patients with osteoarthritis of the knee. (Abstract). Arthritis Rheum 36 Suppl 9 (1993) 165
48. Neustadt D., Caldwell J., Bell M., Wade J., and Gimbel J. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled multicenter trial. J Rheumatol 32 10 (2005) 1928-1936
49. Petrella R.J., DiSilvestro M.D., and Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee. A randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 162 (2002) 292-298
50. Pham T., Le Henanff A., Ravaud P., Dieppe P., Brin S., Paolozzi L., et al. Lack of symptomatic and structural efficacy of a new hyaluronic acid (HA) compound (NRD101), when compared to diacerein and placebo in a one-year controlled study in symptomatic knee osteoarthritis. (Abstract). Arthritis Rheum 48 Suppl 9 (2003) 698
51. Pham T., Le Henanff A., Ravaud Ph., Dieppe P., Paolozzi L., and Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis 63 (2004) 1611-1617
52. Puhl W., Bernau A., Greiling H., Kopcke W., Pforringer W., Steck K.J., et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cartilage 1 (1993) 233-241
53. Russell I.J., Michalek J.E., Lawrence V.A., Lessard J.A., Briggs B.T., and May G.S. A randomized, placebo (PL) and no-intervention (NI) controlled, trial of intra-articular (IA) 1% sodium hyaluronate (HA) in the treatment of knee osteoarthritis (OA). (Abstract). Arthritis Rheum 35 Suppl (1992) 132
54. Scale D., Wobig M., and Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res 55 (1994) 220-232
55. Sezgin M., Demirel A.C., Karaca C., Ortancil O., Ulkar G.B., Kanik A., et al. Does hyaluronan affect inflammatory cytokines in knee osteoarthritis?. Rheumatol Int 25 4 (2005) 264-269
56. Shichikawa K. Evaluation of the effect of sodium hyaluronate (SPH) to osteoarthritis of the knee. The Ryumachi 23 (1983) 280-290
57. Shichikawa K., Igarashi M., Sugawara S., and Iwasaki Y. Clinical evaluation of high molecular weight sodium hyaluronate (SPH) on osteoarthritis of the knee - a multi-center well controlled comparative study. Jap J Clin Pharmacol Therapeutics 14 (1983) 545-558
58. Dixon A.St.J., Jacoby R.K., Berry H., and Hamilton E.B.D. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 11 (1988) 205-213
59. Tamir E., Robinson D., Koren R., Agar G., and Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double-blind, placebo controlled study. Clin Exp Rheumatol 19 (2001) 265-270
60. Tsai C.-L., Chang C.-C., Chen S.-C., Beinat L., and Piva S. Treatment of knee osteoarthritis in Asian population with an intra-articlar hyaluronan of MW 500-730 KDA. (Abstract) Osteoarthritis Cartilage 11 Suppl A (2003) S119
61. Wobig M., Dickhut A., Maier R., and Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20 (1998) 410-423
62. Wobig M., Bach G., Beks P., Dickhut A., Runzheimer J., Schwieger G., et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 21 (1999) 1549-1562
63. Wu J.J., Shih L.Y., Hsu H.C., and Chen T.H. The double-blind test of sodium hyaluronate (Artz) on osteoarthritis knee. Chin Med J (Taipei) 59 (1997) 99-106
64. Bellamy N., Kirwan J., Boers M., Brooks P., Strand V., Altman R., et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 24 (1997) 799-802
65. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J.M., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary. Controlled Clin Trials 17 (1996) 1-12
66. Maher C.G., Sherrington C., Herbert R.D., Moseley A.M., and Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 83 8 (2003) 713-721
67. Chalmers T.C., Smith Jr. H., Blackburn B., Silverman B., Schroeder B., Reitman D., et al. A method for assessing the quality of a randomized control trial. Controlled Clin Trials 2 (1981) 31-49
68. Stevinson C., and Lawlor D.A. Searching multiple databases for systematic reviews: added value or diminishing returns?. Complementary Therap Med 12 (2004) 228-232
69. Ramos-Remus C., Suarez-Almazor M., Dorgn M., Gomez-Vargas A., and Russell A.S. Performance of online biomedical databases in rheumatology. J Rheumatol 21 (1994) 1912-1921
70. McAuley L., Pham B., Tugwell P., and Moher. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses. Lancet 356 (2000) 1228-1231
71. McAlindon T.E., LaValley M.P., Gulin J.P., and Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis. JAMA 283 (2000) 1469-1475
72. Jones A.P., Remmington T., Williamson P.R., Ashby D., and Smyth R.L. High prevalence but low impact of data extraction and reporting errors were found in Cochrane systematic reviews. J Clin Epidemiol 58 (2005) 741-742
73. Sutton A.J., Muir K.R., and Jones A.C. Two knees or one person: data analysis strategies for paired joints or organs. Ann Rheum Dis 56 (1997) 401-402
74. Zhang Y., Glynn R.J., and Felson D.T. Musculoskeletal disease research: should we analyze the joint or the person?. J Rheumatol 23 (1996) 1130-1134
75. Deeks J, Higgins J, Altman D on behalf of the Cochrane Statistical Methods Group. Analysing and presenting results. In The Cochrane Reviewers Handbook 4.2.2.
76. Norman G.R. Issues in the use of change scores in randomized trials. J Clin Epidemiol 42 (1989) 1097-1105
77. Vickers A.J., and Altman D.G. Analysing controlled trials with baseline and follow up measurements. BMJ 323 (2001) 1123-4
78. Cronbach L.J., and Furby L. How we should measure "change" - or should we?. Psychol Bull 74 (1970) 68-80
79. Nesselroade J.R., Stigler S.M., and Baltes P.B. Regression toward the mean and study of change. Psychol Bull 88 (1980) 622-637
80. Stucki G., Daltroy L., Katz J.N., Johanneson M., and Liang M.H. Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol 49 (1996) 711-717
81. Guyatt G., Walter S., and Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 40 (1987) 171-178
82. Lund T. Some metrical issues with meta-analysis of therapy effects. Scand J Psychol 29 (1988) 1-8
83. Twisk J., and Proper K. Evaluation of the results of a randomized controlled trial: how to define changes between baseline and follow-up. J Clin Epidemiol 57 (2004) 223-228
84. Hayden J, Tomlinson G. Follow-up or change scores: does it matter which outcome is used in meta-analysis of randomized controlled trials? (Abstract) The Cochrane Collaboration 2005 Colloquium Abstract O-05.
85. Husted J.A., Cook R.J., Farewell V.T., and Gladman D.D. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 53 (2000) 459-468
86. Zou G.Y. Quantifying responsiveness of quality of life measures without an external criterion. Qual Life Res 14 (2005) 1545-1552
87. Blanchard C., Feeny D., Mahon J.L., Bourne R., Rorabeck C., Stitt L., et al. Is the Health Utilities Index responsive in total hip arthroplasty patients?. J Clin Epidemiol 56 (2003) 1046-1054
88. Liang M.H., Larson M.G., Cullen K.E., and Schwartz J.A. Comparative measurement efficiency and sensitivity of the five health status instruments for arthritis research. Arthritis Rheum 28 (1985) 542-547
89. Roos EM, Nilsdotter AK, Toksvig-Laren S., Patients expectations suggest additional outcomes in total knee replacement. (Abstract) Arthritis Rheum 2000;46 (Suppl 9):S199.
90. Heck D.A., Robinson R.L., Partridge C.M., Lubitz R.M., and Freund D.A. Patient outcomes after knee replacement. Clin Orthop 356 (1998) 93-110
91. Fortin P.R., Clarke A.E., Joseph L., Liang M.H., Tanzer M., and Ferland D. Outcomes of total hip and knee replacement. Preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum 42 8 (1999) 1722-1728
92. Barton-Hanson N.G., Finley R., and Parkinson R.W. Poor validity of the two most commonly used outcome questionnaires in total knee replacement. Validity of: Hospital for Special Surgery (HSS), Knee Society (KSS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores compared. J Bone Joint Surg 81-B Suppl II (1999) 216
93. Lingard E.A., Katz J.N., Wright R.J., Wright E.A., Sledge C.B., and the Kinemax Outcomes Group. Validity and responsiveness of the Knee Society clinical rating system in comparison with the SF-36 and the WOMAC. J Bone Joint Surg 83-A 12 (2001) 1856-1864
94. Bachmeier C.J.M., March L.M., Cross M.J., Lapsley H.M., Tribe K.L., and Courtenay B.G. A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery. Osteoarthritis Cartilage 9 (2001) 137-146
95. Jones C.A., Voaklander D.C., Johnston W.C., and Suarez-Almazor M.E. The effect of age on pain, function, and quality of life after total hip and knee arthroplasty. Arch Intern Med 161 Feb. 12 (2001) 454-460
96. Jones C.A., Voaklander D.C., Johnston W.C., and Suarez-Almazor M.E. Health related quality of life outcomes after total hip and knee arthroplasties in a community based population. J Rheumatol 27 (2000) 1745-1752
97. Mahomed N.N., Liang M.H., Cook E.F., Daltroy L.H., Fortin P.R., Fossel A.H., et al. The importance of patient expectations in predicting functional outcomes after total joint arthroplasty. J Rheumatol 29 (2002) 1273-1279
98. Parent E., and Moffet H. Comparative responsiveness of locomotor tests and questionnaires used to follow early recovery after total knee arthroplasty. Arch Phys Med Rehabil 83 (2002) 70-80
99. de Craen A.J.M., van Vliet H.A.A.M., and Helmerhorst F.M. An analysis of systematic reviews indicated low incorporation of results from clinical trial quality assessment. J Clin Epidemiol 58 (2005) 311-313
100. Terrin N.C., Schmid C.H., and Lau J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol 58 (2005) 894-901
101. Tang J.L., and Jl L. Misleading funnel plot for detection of bias in meta- analyses. J Clin Epidemiol 53 (2000) 477-484